These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35716171)

  • 21. Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial.
    Upadhyaya SA; Robinson GW; Onar-Thomas A; Orr BA; Billups CA; Bowers DC; Bendel AE; Hassall T; Crawford JR; Partap S; Fisher PG; Tatevossian RG; Seah T; Qaddoumi IA; Vinitsky A; Armstrong GT; Sabin ND; Tinkle CL; Klimo P; Indelicato DJ; Boop FA; Merchant TE; Ellison DW; Gajjar A
    Neuro Oncol; 2019 Oct; 21(10):1319-1330. PubMed ID: 30976811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups.
    Ritzmann TA; Rogers HA; Paine SML; Storer LCD; Jacques TS; Chapman RJ; Ellison D; Donson AM; Foreman NK; Grundy RG
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28426. PubMed ID: 32614133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posterior fossa lateral ependymoma in childhood.
    Nagib MG; O'Fallon MT
    Pediatr Neurosurg; 1996 Jun; 24(6):299-305. PubMed ID: 8988495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of chemotherapy in newly diagnosed ependymoma of childhood.
    Souweidane MM; Bouffet E; Finlay J
    Pediatr Neurosurg; 1998 May; 28(5):273-8. PubMed ID: 9732262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pediatric ependymomas: Current diagnosis and therapy].
    Frappaz D; Vasiljevic A; Beuriat PA; Alapetite C; Grill J; Szathmari A; Faure-Conter C
    Bull Cancer; 2016 Oct; 103(10):869-879. PubMed ID: 27717499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose chemotherapy with autologous stem-cell rescue in patients with recurrent and high-risk pediatric brain tumors.
    Graham ML; Herndon JE; Casey JR; Chaffee S; Ciocci GH; Krischer JP; Kurtzberg J; Laughlin MJ; Longee DC; Olson JF; Paleologus N; Pennington CN; Friedman HS
    J Clin Oncol; 1997 May; 15(5):1814-23. PubMed ID: 9164190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage treatment for childhood ependymoma after surgery only: Pitfalls of omitting "at once" adjuvant treatment.
    Massimino M; Giangaspero F; Garrè ML; Genitori L; Perilongo G; Collini P; Riva D; Valentini L; Scarzello G; Poggi G; Spreafico F; Peretta P; Mascarin M; Modena P; Sozzi G; Bedini N; Biassoni V; Urgesi A; Balestrini MR; Finocchiaro G; Sandri A; Gandola L;
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1440-5. PubMed ID: 16863927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An overview of the management of adult ependymomas with emphasis on relapsed disease.
    Iqbal MS; Lewis J
    Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):726-33. PubMed ID: 23972764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maximally safe resection followed by hypofractionated re-irradiation for locally recurrent ependymoma in children.
    Liu AK; Foreman NK; Gaspar LE; Trinidad E; Handler MH
    Pediatr Blood Cancer; 2009 Jul; 52(7):804-7. PubMed ID: 19260098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in Management of Pediatric Ependymomas.
    Lin FY; Chintagumpala M
    Curr Oncol Rep; 2015 Oct; 17(10):47. PubMed ID: 26369328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of pre-irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: a report from the Children's Oncology Group.
    Garvin JH; Selch MT; Holmes E; Berger MS; Finlay JL; Flannery A; Goldwein JW; Packer RJ; Rorke-Adams LB; Shiminski-Maher T; Sposto R; Stanley P; Tannous R; Pollack IF;
    Pediatr Blood Cancer; 2012 Dec; 59(7):1183-9. PubMed ID: 22949057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after first relapse of childhood intracranial ependymoma.
    Tsai JW; Manoharan N; Alexandrescu S; Zimmerman MA; Scully J; Chordas C; Clymer J; Wright KD; Filbin M; Ullrich NJ; Marcus KJ; Haas-Kogan D; Chi SN; Bandopadhayay P; Yeo KK
    Pediatr Blood Cancer; 2021 Aug; 68(8):e28930. PubMed ID: 33565268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes following proton therapy for pediatric ependymoma.
    Indelicato DJ; Bradley JA; Rotondo RL; Nanda RH; Logie N; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Mendenhall NP
    Acta Oncol; 2018 May; 57(5):644-648. PubMed ID: 29239262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Candidate genes on chromosome 9q33-34 involved in the progression of childhood ependymomas.
    Puget S; Grill J; Valent A; Bieche I; Dantas-Barbosa C; Kauffmann A; Dessen P; Lacroix L; Geoerger B; Job B; Dirven C; Varlet P; Peyre M; Dirks PB; Sainte-Rose C; Vassal G
    J Clin Oncol; 2009 Apr; 27(11):1884-92. PubMed ID: 19289631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of tumor grade on time to progression after irradiation for localized ependymoma in children.
    Merchant TE; Jenkins JJ; Burger PC; Sanford RA; Sherwood SH; Jones-Wallace D; Heideman RL; Thompson SJ; Helton KJ; Kun LE
    Int J Radiat Oncol Biol Phys; 2002 May; 53(1):52-7. PubMed ID: 12007941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extent of re-excision, sequence/timing of salvage re-irradiation, and disease-free interval impact upon clinical outcomes in recurrent/progressive ependymoma.
    Gupta T; Maitre M; Gupta P; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Singh V; Chinnaswamy G; Epari S; Sahay A; Patil V; GodaSastri J
    J Neurooncol; 2020 Apr; 147(2):405-415. PubMed ID: 32072441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child.
    Lassaletta A; Perez-Olleros P; Scaglione C; Sirvent S; De Prada I; Perez-Martinez A; Ruiz-Hernandez A; Madero L
    J Neurooncol; 2007 Jul; 83(3):303-6. PubMed ID: 17245619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ependymoma: a heterogeneous tumor of uncertain origin and limited therapeutic options.
    Dorfer C; Tonn J; Rutka JT
    Handb Clin Neurol; 2016; 134():417-31. PubMed ID: 26948369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy.
    Merchant TE; Haida T; Wang MH; Finlay JL; Leibel SA
    J Neurosurg; 1997 Jun; 86(6):943-9. PubMed ID: 9171172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.